Tachyra 50 mg Injection 3 ml is primarily used to treat arrhythmias (irregular heartbeats). An arrhythmia is a heart rhythm disorder in which the heart may beat too slowly, too fast, or in an uneven pattern.

Tachyra 50 mg Injection 3 ml contains amiodarone, which regulates the heartbeat by altering the electrical impulses passing through the heart. Thereby, Tachyra 50 mg Injection 3 ml helps to restore a regular heart rhythm.

Tachyra 50 mg Injection 3 ml will be administered by a healthcare professional; do not self-administer. Tachyra 50 mg Injection 3 ml may cause side effects such as nausea, loss of appetite, dry mouth, blurred vision, and dizziness. Reach out to your doctor if these side effects persist or worsen

Inform your doctor if you are allergic to it. Let your doctor know if you are pregnant or are breastfeeding before receiving Tachyra 50 mg Injection 3 ml. Keep your doctor informed about your health condition and medications to rule out any side effects.

Tachyra 50 mg Injection 3 ml is used to treat and prevent various types of serious irregular heartbeats (arrhythmias). The detailed uses of Tachyra 50 mg Injection 3 ml are as follows:

• Treatment of ventricular arrhythmias: Tachyra 50 mg Injection 3 ml is effective in managing life-threatening arrhythmias such as ventricular tachycardia and ventricular fibrillation.
• Management of supraventricular arrhythmias: Tachyra 50 mg Injection 3 ml helps in controlling abnormal heart rhythms originating above the ventricles, including atrial fibrillation and atrial flutter.
• Restores normal heart rhythm: Tachyra 50 mg Injection 3 ml works by blocking abnormal electrical signals in the heart, helping to maintain a steady and regular heartbeat.
• Long-term prevention of arrhythmias: Tachyra 50 mg Injection 3 ml is used to prevent recurrence of serious arrhythmias in patients at risk.

• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safe and effective use.
• Tachyra 50 mg Injection 3 ml will be administered by the doctor.
• Do not self-administer.

• Tachyra 50 mg Injection 3 ml belongs to a class of antiarrhythmic medications primarily used to treat arrhythmias (irregular heartbeats).
• Tachyra 50 mg Injection 3 ml contains amiodarone as an active ingredient.
• It acts by blocking the potassium channels in the heart.
• Irregular heartbeat occurs due to abnormal electrical activity or the impulses produced in the heart.
• Tachyra 50 mg Injection 3 ml blocks these abnormal electric signals and regulates the heartbeat.

• Do not use Tachyra 50 mg Injection 3 ml if you are allergic to iodine, amiodarone, or any other antiarrhythmic drugs.
• Also, avoid taking Tachyra 50 mg Injection 3 ml if you have atrioventricular (AV) or sinoatrial (SA) heart block (disorders in the rhythm of the heart), unless you have a pacemaker or a history of sinus bradycardia (slow heartbeats), or if your heart cannot pump blood properly.
• Tachyra 50 mg Injection 3 ml contains lactose, so patients having lactose intolerance should not take it.
• Inform your doctor if you have breathing problems, vision problems, high/low blood pressure, thyroid disorder, electrolyte imbalance, if you have a pacemaker or defibrillator implantation.
• Inform your doctor if you are above 65 years old, have liver problems, have lung problems such as asthma, have optic neuritis (eye problem), or are undergoing surgery.
• Inform your doctor if you have Stevens-Johnson syndrome (flu-like symptoms followed by rashes and blistering of the skin) or toxic epidermal necrolysis (a skin condition characterized by flu-like symptoms, chills, rashes, and peeling of the skin), as Tachyra 50 mg Injection 3 ml can worsen the condition.